Delta-Fly Pharmaの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/03/23 | 1,410 | 1,430 | 1,345 | 1,357 | -39 | -2.8% | 287,300 |
2021/03/22 | 1,385 | 1,448 | 1,360 | 1,396 | +25 | +1.8% | 398,900 |
2021/03/19 | 1,251 | 1,385 | 1,242 | 1,371 | +111 | +8.8% | 333,900 |
2021/03/18 | 1,310 | 1,335 | 1,236 | 1,260 | -13 | -1% | 257,400 |
2021/03/17 | 1,235 | 1,312 | 1,210 | 1,273 | +24 | +1.9% | 331,900 |
2021/03/16 | 1,146 | 1,254 | 1,135 | 1,249 | +104 | +9.1% | 165,900 |
2021/03/15 | 1,130 | 1,149 | 1,120 | 1,145 | +21 | +1.9% | 53,300 |
2021/03/12 | 1,116 | 1,125 | 1,096 | 1,124 | +18 | +1.6% | 52,800 |
2021/03/11 | 1,100 | 1,111 | 1,073 | 1,106 | +16 | +1.5% | 40,700 |
2021/03/10 | 1,070 | 1,100 | 1,070 | 1,090 | +20 | +1.9% | 65,300 |
2021/03/09 | 1,054 | 1,078 | 1,026 | 1,070 | +22 | +2.1% | 69,500 |
2021/03/08 | 1,082 | 1,102 | 1,040 | 1,048 | -19 | -1.8% | 86,300 |
2021/03/05 | 1,090 | 1,099 | 1,012 | 1,067 | -36 | -3.3% | 186,800 |
2021/03/04 | 1,138 | 1,151 | 1,087 | 1,103 | -35 | -3.1% | 112,400 |
2021/03/03 | 1,151 | 1,157 | 1,132 | 1,138 | -3 | -0.3% | 44,300 |
2021/03/02 | 1,179 | 1,195 | 1,126 | 1,141 | -24 | -2.1% | 92,300 |
2021/03/01 | 1,169 | 1,183 | 1,137 | 1,165 | +12 | +1% | 99,400 |
2021/02/26 | 1,132 | 1,175 | 1,105 | 1,153 | +13 | +1.1% | 108,100 |
2021/02/25 | 1,143 | 1,154 | 1,117 | 1,140 | +27 | +2.4% | 47,900 |
2021/02/24 | 1,155 | 1,175 | 1,113 | 1,113 | -52 | -4.5% | 75,700 |
2021/02/22 | 1,110 | 1,172 | 1,103 | 1,165 | +51 | +4.6% | 71,200 |
2021/02/19 | 1,126 | 1,134 | 1,081 | 1,114 | -12 | -1.1% | 66,200 |
2021/02/18 | 1,158 | 1,166 | 1,123 | 1,126 | -27 | -2.3% | 56,900 |
2021/02/17 | 1,110 | 1,157 | 1,110 | 1,153 | +33 | +2.9% | 60,500 |
2021/02/16 | 1,100 | 1,134 | 1,090 | 1,120 | +16 | +1.4% | 77,800 |
2021/02/15 | 1,110 | 1,116 | 1,060 | 1,104 | ±0 | ±0% | 117,500 |
2021/02/12 | 1,120 | 1,123 | 1,090 | 1,104 | -25 | -2.2% | 97,900 |
2021/02/10 | 1,127 | 1,138 | 1,115 | 1,129 | -18 | -1.6% | 95,400 |
2021/02/09 | 1,180 | 1,209 | 1,135 | 1,147 | -3 | -0.3% | 273,000 |
2021/02/08 | 1,181 | 1,181 | 1,130 | 1,150 | -32 | -2.7% | 108,500 |
2021/02/05 | 1,165 | 1,184 | 1,141 | 1,182 | +16 | +1.4% | 93,500 |
2021/02/04 | 1,150 | 1,168 | 1,126 | 1,166 | +22 | +1.9% | 78,300 |
2021/02/03 | 1,140 | 1,160 | 1,112 | 1,144 | +16 | +1.4% | 87,700 |
2021/02/02 | 1,108 | 1,134 | 1,076 | 1,128 | +30 | +2.7% | 88,800 |
2021/02/01 | 1,103 | 1,108 | 1,057 | 1,098 | -21 | -1.9% | 108,600 |
2021/01/29 | 1,163 | 1,177 | 1,104 | 1,119 | -41 | -3.5% | 169,700 |
2021/01/28 | 1,162 | 1,185 | 1,149 | 1,160 | -32 | -2.7% | 90,000 |
2021/01/27 | 1,211 | 1,254 | 1,180 | 1,192 | -19 | -1.6% | 110,500 |
2021/01/26 | 1,242 | 1,253 | 1,206 | 1,211 | -30 | -2.4% | 67,500 |
2021/01/25 | 1,240 | 1,249 | 1,214 | 1,241 | +1 | +0.1% | 72,100 |
2021/01/22 | 1,236 | 1,260 | 1,207 | 1,240 | -7 | -0.6% | 86,000 |
2021/01/21 | 1,245 | 1,250 | 1,202 | 1,247 | -6 | -0.5% | 113,800 |
2021/01/20 | 1,222 | 1,260 | 1,220 | 1,253 | +31 | +2.5% | 89,200 |
2021/01/19 | 1,218 | 1,228 | 1,199 | 1,222 | +2 | +0.2% | 90,900 |
2021/01/18 | 1,202 | 1,282 | 1,200 | 1,220 | -3 | -0.2% | 178,800 |
2021/01/15 | 1,178 | 1,241 | 1,160 | 1,223 | +45 | +3.8% | 164,600 |
2021/01/14 | 1,169 | 1,201 | 1,165 | 1,178 | ±0 | ±0% | 88,300 |
2021/01/13 | 1,202 | 1,227 | 1,165 | 1,178 | -24 | -2% | 113,900 |
2021/01/12 | 1,231 | 1,252 | 1,201 | 1,202 | -56 | -4.5% | 140,500 |
2021/01/08 | 1,229 | 1,272 | 1,199 | 1,258 | +85 | +7.2% | 265,000 |
901~
950
件表示中 / 1492件
類似銘柄と比較する
現在ご覧いただいている「DELTA-P」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
DELTA-P | 51,900円 | - | - | 0.00% | - | 14.89倍 |
|
創薬ベンチャー。既存の抗がん物質を組み合わせて安全性と有効性を高めた抗がん剤を開発 |
キッズバイオ | 12,100円 | - | - | 0.00% | - | 6.37倍 |
|
北大発創薬ベンチャー。バイオ後続品を主力に、乳歯歯髄幹細胞(SHED)用いた再生医療に力 |
ブライトパス | 5,600円 | - | - | 0.00% | - | 3.94倍 |
|
久留米大学発創薬ベンチャー。がん向け遺伝子導入iPS由来細胞医薬や抗体医薬開発に注力 |
免疫生物 | 50,000円 | +13.4% | -4.0% | 0.00% | 40.49倍 | 3.49倍 |
|
研究用試薬の製販・受託。遺伝子組み換えカイコの基礎研究は休止し、化粧品等応用開発に移行 |
ファンペップ | 14,000円 | - | - | 0.00% | - | 2.12倍 |
|
大阪大医研発。患者の体内で抗体の産生を誘導する抗体誘導ペプチドを用いた医薬品を開発 |
市場注目の銘柄
チャート関連のコラム